Upper Airway Disease: Allergic Rhinitis, Sinusitis, and Streptococcal Pharyngitis: Assessment, Analysis, and Associated Dental Management Guidelines

2017 ◽  
pp. 337-340
Keyword(s):  
Allergic Rhinitis ◽  
Upper Airway ◽  
Airway Disease ◽  
Streptococcal Pharyngitis ◽  
Management Guidelines ◽  
Dental Management ◽  
Upper Airway Disease

Effects of air pollutants on upper airway disease

2016 ◽  
Vol 16 (1) ◽  
pp. 13-17 ◽  
Author(s):  
An-Soo Jang ◽  
Young Joon Jun ◽  
Moo Kyun Park
Keyword(s):  
Air Pollutants ◽  
Upper Airway ◽  
Airway Disease ◽  
Upper Airway Disease

Activin-A Is a Pro-Inflammatory Regulator in Type-2-Driven Upper Airway Disease

2018 ◽  
Vol 176 (1) ◽  
pp. 15-25 ◽  
Author(s):  
Adam M. Chaker ◽  
Ulrich Matthias Zissler ◽  
Nikolaos Poulos ◽  
Martin Wagenmann ◽  
Murat Bas ◽  
...  
Keyword(s):  
Upper Airway ◽  
Airway Disease ◽  
Activin A ◽  
Upper Airway Disease

scholarly journals Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Valerie Hox ◽  
Evelijn Lourijsen ◽  
Arnout Jordens ◽  
Kristian Aasbjerg ◽  
Ioana Agache ◽  
...  
Keyword(s):  
Upper Airway ◽  
Airway Disease ◽  
Systemic Steroid ◽  
Systemic Steroids ◽  
Consensus Document ◽  
Airway Diseases ◽  
Short And Long Term ◽  
International Experts ◽  
Upper Airway Disease

Abstract Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that—potentially severe—side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.

Association between the use of electronic cigarettes and the prevalence of chronic rhinosinusitis and allergic rhinitis: a nationwide cross-sectional study

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
M.-S. Rha ◽  
H.-J. Cho ◽  
J.-H. Yoon ◽  
C.-H. Kim
Keyword(s):  
Allergic Rhinitis ◽  
Chronic Rhinosinusitis ◽  
Electronic Cigarettes ◽  
Adult Population ◽  
Upper Airway ◽  
Airway Disease ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Health And Nutrition ◽  
High Prevalence

Background: Whether the use of electronic cigarettes (ECs) is associated with upper airway diseases, including chronic rhinosinusitis (CRS) and allergic rhinitis (AR), remains unclear. Methods: We analyzed data from the nationwide cross-sectional surveys: the Korea National Health and Nutrition Examination Survey VI (2013–2015), VII (2016–2018), and VIII (2019). Logistic regression analysis was performed to assess the association between EC use and CRS or AR. Results: Among a total of 38,413 participants, 6.4% were former EC users and 2.5% were current EC users. Former EC users and current EC showed a significantly increased OR for CRS or AR compared with never EC users. In the subgroup analysis, the “current CC (conventional cigarette)-current EC” and the “current CC-formal EC” group had a significantly higher OR for CRS or AR than the “current CC-never EC” group. In addition, former CC smokers who currently use ECs showed a significantly higher OR for AR than former CC smokers without EC use. Conclusions: EC use is significantly associated with a high prevalence of CRS and AR in the adult population. These results indicate that the use of ECs may increase the risk of upper airway disease.

Sign in / Sign up

Export Citation Format

Share Document